Toxicity evaluation for an Enterococcus faecium strain TM39 in vitro and in vivo

Food and Chemical Toxicology

Volumn 42, Issue 10, 2004, Pages 1601-1609

  Tsai, Cheng Chih ^a   Liu, Tseng Huang ^a   Chen, Ming Hui ^a   Tsai, Chin Chuan ^b   Tsen, Hau Yang ^c  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

Enterococcus faecium; Invasion; Probiotic; Toxicity; Wistar rats

Indexed keywords

AMPICILLIN; BETA LACTAMASE; CARBENICILLIN; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; LINCOMYCIN; METICILLIN; NEOMYCIN; OFLOXACIN; OXACILLIN; PENICILLIN G; STREPTOMYCIN; SULFAMETHOXAZOLE; TRIMETHOPRIM; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BEHAVIOR; BODY WEIGHT; CELL LINE; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; FEMALE; FLUID INTAKE; FOOD INTAKE; GROWTH; HEMATOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; NONHUMAN; RAT; STOMACH CARCINOMA; TOXICITY TESTING;

ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; HELICOBACTER; HELICOBACTER PYLORI; RATTUS NORVEGICUS;

EID: 4043101067     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2004.05.005     Document Type: Article

References (42)

1. Advisory Committee on Novel Foods and Process, 1996. Report on Enterococcus faecium strain K77D MATF. Advisory Committee on Novel Food and Processes. Ergon House and Nobel House, 17 Smith Square, London SW1 3JR, UK
2. Armuzzi A., Cremonini F., Bartolozzi F., Candelli M., Ojetti V., Cammarota G., Anti M., De Lorenzo A., Pola P., Gasbarrini G., Gasbarrini A. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Alimentary Pharmacology and Therapeutics. 15:2001;163-169
3. Beukes E.M., Bester B.H., Mostert J.F. The microbiology of South African traditional fermented milks. International Journal of Food Microbiology. 63:2001;189-197
4. Blaser M.J. Helicobacter pylori: microbiology of a slow bacterial infection. Trends in Microbiology. 1:1993;255-260
5. Canducci F., Armuzzi A., Cremonini F., Cammarota G., Bartolozzi F., Pola P., Gasbarrini G., Gasbarrini A. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Alimentary Pharmacology and Therapeutics. 14:2000;1625-1629
6. Coconnier M.H., Lievin V., Hemery E., Servin A. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Applied and Environmental Microbiology. 64:1998;4573-4580
7. Delaney B., Carlson T., Frazer S., Zheng T., Hess R., Ostergren K., Kierzek K., Haworth J., Knutson N., Junker K., Jonker D. Evaluation of the toxicity of concentrated barley β-glucan in a 28-day feeding study in Wistar rats. Food and Chemical Toxicology. 41:2003;477-487
8. Donohue D., Salminen S. Safety of probiotic bacteria. Asia Pacific Journal of Clinical Nutrition. 5:1996;25-28
9. Donohue D., Salminen S. Safety of Lactobacillus GG (ATCC 53103). Nutrition Today. 31:1996;12s-15s
10. Donohue D., Deighton M., Ahokas J.T., Salminen S. Toxicity of lactic acid bacteria. Salminen S., von Wright A. Lactic Acid Bacteria. 1993;307-313 Marcel Dekker Inc., New York
11. Dutka-Malen S., Evers S., Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. Journal of Clinical Microbiology. 33:1995;24-27
12. FAO/WHO, 2001. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Available from 〈http://www.fao.org/es/ESN/Probio/report.pdf〉
13. Ford H.R., Avanoglu A., Boechat P.R., Melgoza R., Lum-Cheong R.S., Boyle P., Garrett M., Rowe M.I. The microenvironment influences the pattern of bacterial translocation in formula-fed neonates. Journal of Pediatrics Surgery. 31:1996;486-489
14. Franz C.M.A.P., Holzapfel W.H., Stiles M.E. Enterococci at the crossroads of food safety. International Journal of Food Microbiology. 47:1999;1-24
15. Franz C.M.A.P., Albrecht B., Muscholl-Silberhorn N.M.K., Yousif M.V., Jean S., Wilhelm H.H. Incidence of virulence factors and antibiotic resistance among Enterococci isolated from food. Applied and Environmental Microbiology. 67:2001;4385-4389
16. Fris-Møller A., Hey H. Colonization of the intestinal canal with a Streptococcus faecium preparation (Paraghurt). Current Therapeutic Research. 33:1983;807-815
17. Fuller R.J. Probiotics in man and animals. Journal of Applied Bacteriology. 66:1989;365-378
18. Fuller R. Probiotics in human medicine. Gut. 32:1991;439-442
19. Giraffa G., Sisto F. Susceptibility to vancomycin of enterococci isolated from dairy products. Letter Applied Microbiology. 25:1997;335-338
20. Giraffa G., Picchioni N., Neviani E., Carminati D. Production and stability of an Enterococcus faecium bacteriocin during Taleggio cheese making and ripening. Food Microbiology. 12:1995;301-307
21. Kariyama R., Mitsuhata R., Chow J.W., Clewell D.B., Kumon H. Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci. Journal of Clinical Microbiology. 38:2000;3092-3095
22. Katz M., Medina R., Gonzalez S., Oliver G. Esterolytic and lipolytic activities of lactic acid bacteria isolated from ewe's milk and cheese. Journal of Food Protection. 65:2002;1997-2001
23. Lalonde M., Segura M., Lacouture S., Gottschalk M. Interactions between Streptococcus suis serotype 2 and different epithelial cell lines. Microbiology. 146:2000;1913-1921
24. Leroy F., Foulquie Moreno M.R., De Vuyst L. Enterococcus faecium RZS C5, an interesting bacteriocin producer to be used as a co-culture in food fermentation. International Journal of Food Microbiology. 88:2003;235-240
25. Lewenstein A., Frigerio G., Moroni M. Biological properties of SF, a new approach for the treatment of diarrheal diseases. Current Therapeutic Research. 26:1979;967-981
26. Lund B., Edlund C., Barkholt L. Impact on human intestinal microflora of an faecium probiotic and vancomycin. Scandinavian Journal of Infectious Diseases. 32:2000;627-632
27. Marteau P.R., de Vrese M., Cellier C.J., Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. American Journal of Clinical Nutrition. 73:2001;430S-436S
28. McConnel M.A., Mercer A.A., Tannock G.W. Transfer of plasmid pAMβ1 between members of the normal microflora inhabiting the murine digestive tract and modification of the plasmid in a Lactobacillus reuteri host. Microbial Ecology in Health and Disease. 4:1991;343-355
29. Medina R., Katz M., Gonzalez S., Oliver G. Characterization of the lactic acid bacteria in ewe's milk and cheese from northwest Argentina. Journal of Food Protection. 64:2001;559-563
30. Midolo P.D., Lambert J.R., Hull R., Luo F., Grayson M.L. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. Journal of Applied Bacteriology. 79:1995;475-479
31. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests. M2-A6, 6th ed. Villanova, PA, National Committee for Clinical Laboratory Standard, 1998
32. Parsonnet J., Vandersteen D., Goates J., Sibley R.K., Pritikin J., Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. Journal of the National Cancer Institute. 83:1991;640-643
33. Perdigon G., Nader de Macias M.E., Alvarez S., Oliver G., Pesce de Ruiz Holgado A.A. Enhancement of immune response in mice fed with Streptococcus thermophilus and Lactobacillus acidophilus. Journal of Dairy Science. 70:1987;919-926
34. Rolfe R.D. The role of probiotic cultures in the control of gastrointestinal health. Journal of Nutrition. 130:2000;396S-402S
35. Saavedra L., Taranto M.P., Sesma F., de Valdez G.F. Homemade traditional cheeses for the isolation of probiotic Enterococcus faecium strains. International Journal of Food Microbiology. 88:2003;241-245
36. Safdar A., Bryan C.S., Stinson S., Saunders D.E. Prosthetic valve endocarditis due to vancomycin-resistant Enterococcus faecium: treatment with chloramphenicol plus minocycline. Clinical Infectious Diseases. 34:2002;E61-E63
37. Sakamoto I., Igarashi M., Kimura K., Takagi A., Miwa T., Koga Y. Suppressive effect of Lactobacillus gasseri OLL2716 (LG21) on Helicobacter pylori infection in humans. Journal of Antimicrobial Chemotherapy. 47:2001;709-710
38. Swendseid M.E. Biochemical assessment of protein and amino acid status. Livingston G.E. Proceedings of a National Conference Sponsored by the Food and Nutrition Council of the American Health Foundation, Nutritional Status Assessment of the Individual. 1987;205-211 Food and Nutrition Press, New York
39. Tang P., Foubister V., Pucciarelli M.G., Finlay B.B. Methods to study bacterial invasion. Journal of Microbiology Method. 18:1993;227-240
40. Tortuero F., Rioperez J., Fernandez E., Rodriguz M.L. Response of piglets to oral administration of lactic acid bacteria. Journal of Food Protection. 58:1995;1369-1374
41. Tsai, C.C., Huang, L.F., Lin, C.C., Tsen, H.Y., in press. Antagonistic activity against Helicobacter pylori infection in vitro by a strain of Enterococcus faecium TM39. International Journal of Food microbiology
42. Zhou J.S., Shu Q., Rutherfurd K.J., Prasad J., Birtles M.J., Gopal P.K., Gill H.S. Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice. International Journal of Food Microbiology. 56:2000;87-96